Weekly Journal Scan: spironolactone does not ACHIEVE reduction of cardiovascular outcomes in dialysis patients [0.03%]
本周期刊扫描：螺内酯不能降低透析患者的临床预后指标
Daniela Pedicino,Carlo Patrono
Daniela Pedicino
Weekly Journal Scan: Rethinking dual antiplatelet therapy after coronary artery bypass grafting for acute coronary syndromes [0.03%]
周刊导读：急性冠脉综合征冠状动脉旁路移植术后双联抗血小板治疗的再思考
Giovanna Liuzzo,Carlo Patrono
Giovanna Liuzzo
High-sensitivity cardiac troponin I and risk of dementia: the 25-year longitudinal Whitehall II study [0.03%]
高敏心肌肌钙蛋白I与痴呆风险的关系：白厅II研究25年纵向资料的分析结果
Yuntao Chen,Martin Shipley,Atul Anand et al.
Yuntao Chen et al.
Background and aims: This study hypothesizes that subclinical myocardial injury during midlife, indexed by increases in cardiac troponin I, is associated with accelerated cognitive decline, smaller structural brain volume...
Vidhushei Yogeswaran,Catherine M Otto
Vidhushei Yogeswaran
Bridging The Gaps In EMPEROR-Preserved: Toward safer and smarter use of Empagliflozin in resistant hypertension and heart failure with preserved ejection fraction [0.03%]
EMPEROR- Preserve研究解读：心力衰竭和射血分数保留高血压患者使用恩格列净的优化策略
Maham Fatima,Sajal Sheikh,Zara Ammer
Maham Fatima
Uniform benefits of empagliflozin across hypertension categories: a response [0.03%]
恩格列净对各类高血压患者的疗效一致性的回应
Mert Tokcan,Philipp Markwirth,Michael Böhm
Mert Tokcan
Transgender persons receiving gender-affirming hormone therapy: risk of acute cardiovascular events in a Dutch cohort study [0.03%]
接受性别肯定激素治疗的跨性别者急性心血管事件风险：一项来自荷兰队列研究的结果
Lieve Mees van Zijverden,Abel Thijs,Jeske Joanna Katarina van Diemen et al.
Lieve Mees van Zijverden et al.
Background and aims: Despite favourable effects of oestradiol on cardiovascular risk factors, previous studies found higher risks of cardiovascular events in transgender women using gender-affirming hormone therapy. Howev...
Genetic evaluation of early-onset atrial fibrillation: impact on patient management [0.03%]
早发性房颤的基因评估对患者管理的影响
J Lukas Laws,Mahsima Shabani,Hollie L Williams et al.
J Lukas Laws et al.
Background and aims: Genetic testing is recommended for select patients with atrial fibrillation (AF). The aims of this study were to define the results of genetic evaluation and its therapeutic impact for patients referr...
Reclassifying myocardial infarction: from ST elevation to coronary occlusion [0.03%]
从ST段抬高到冠状动脉阻塞：重新划分心肌梗死类型
Mohammed Ayyad,Maram Albandak,Joseph Allencherril
Mohammed Ayyad